2767 Second line systemic treatment options for recurrent/advanced cervical cancer - The Royal Marsden experience. (September 2015) - Boussios, S.; Glaessgen, D.; Okines, A.; Lalondrelle, S.; Taylor, A.; McLachlan, J.; Gore, M.; Kaye, S.; Banerjee, S.